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Summary: Proteoglycan monomers from the articular cartilages of the knee, hip and shoulder of 3 subjects
(21, 26 and 45 years old) were isolated and analysed. The proteoglycan monomers from the high weight-
bearing knee and hip joints were smaller than those from the low weight-bearing shoulder joints and both
had a lower chondroitin sulphate content. The proteoglycan monomers from knee joint cartilage had the
lowest intra-individual chondroitin-4rsulphate content in each case. Hyaluronate binding capacity was not
found to be dependent on joint location.
Der Einfluß der Gelenklokalisation auf die Struktur menschlicher Knorpelproteoglykane
Zusammenfassung: Pröteoglykanmonomere aus den Gelenkknorpeln der Knie, Hüfte und Schulter wurden
bei 3 Probanden (21, 25 und 45 Jahre alt) isoliert und analysiert. Die Pröteoglykanmonomere der hoch
gewichtsbelä$teten Knie- und Hüftgelenke erwiesen sich als kleiner als die der weniger gewichtsbelasteten
Schultergelenke und hatten jeweils einen niedrigeren Chondroitinsulfatgehalt. Die Pröteoglykanmonomere
der Kniegelenkknorpel zeigten intraindividuell jeweils den niedrigsten Anteil Chondroitin-4-sulfat. Eine
Abhängigkeit der Hyalüronatbindungsfähigkeit von der Gelenklokalisation wurde nicht festgestellt.
Introduction tissue components has been investigated continu-
Since the first description by Hascall & Sajdera (1) ously. Varying structures can be assigned to different
of a methodt for isplating intact proteoglycans from tissues (see Hascall & Kimura (2) for a review). The
cartilage tissue, the structüre of these connective proteoglycans of hyaline articular cartilage contain a
central core protein. Roughly two-thirds of this pro-
tein are occupied by glycosaminoglycan side-chains,
») Supported by the Deutsche Forschungsgemeinschaft (SFB ^^ One-third being assigned to the chrondroitin
*) TÄs work contains parts of the doctoral thesis of sulphate-rich region and one-third to the keratan
G. Pallasch. sulphate-rich region. The remaming one-third is de-
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void of glycosaminoglycans and binds to hyaluronic
acid. Systematic structural changes have been de-
scribed in connection with ageing processes and dege-
nerative disorders (3).
The extent to which functional biomechanical Stresses
on the joints might contribute to.these changes re-
mains uncertain. In vitro studies have demonstrated
that mechanical Stresses affect the biosynthesis and.
breakdown of cartilage proteoglycans (4, 5). In in
vivo studies, proteoglycans with differing structures
have been detected in rabbit knee joint cartilage sub-
jected to varying stress: the proteoglycans of the
higher weight-bearing joints contained a greater gly-
cosamine portion, indicating a larger keratan sul-
phate region (6). In contrast, comparative analysis of
proteoglycans from high weight-bearing human knee
joint cartilage and low weight-bearing human shoul-
der joint cartilage failed to disclose any intra-indivi-
dual structural differences (7). However, apart from
one 34-year-old, all the subjects studied were 15 years
old or less.
It was of interest to establish whether this fmding
also applies for proteoglycans from adült human
articular cartilage, or whether proteoglycan structure
is demonstrably affected by weight-bearing differen-
ces. Proteoglycans from the articular cartilage of
shoulder, hip and knee of adult subjects were there-




Human articular cartilage was obtained from the shoulder, hip
and knee of 3 subjects (21, 26 and 45 years oid) within 24h
post mortem. Left and right joints were investigated in parallel,
except in the case of the 45-year-old subject where the right
joints only were analysed. There was no clinical or macroscopic
evidence of joint disease or of damage due to trauma. Histologi-
cal examination after staining with safranin O and haematoxy-
-lin-eosin (8) revealed normal cartilage structure without any
indication of pathological change.
Chemicals
The following materials were purchased from commercial sour-
ces: papain from Boehringer Mannheim (Mannheim, FRG),
hyaluronate lyase (EC 4.2.99.1) from E. Merck (Darmstadt,
FRG), chrondroitinase AC (EC 4.2.2.5), chondroitinase ABC
(EC 4.2.2.4), hyaluronic acid (human umbilical cord), 6-amino-
hexanoic acid and soya bean trypsin inhibitor from the Sigma
Chemical Company (Munich, FRG), Standard disaccharides
(2-acetamido-2-deoxy-3-O-(ß-Z)-gluco-4-enepyranosyluronic
acid)-Z)-galactose ( DiOS), 2-acetamido-2-deoxy-3-O-(ß-D-
gluco-4-enepyranosyluronic acid)-4-O-sulpho-Z)-gälactose (
Di4S), 2-acetamido-2-deoxyr3-O-(ß-/)-gluco-4-enepyranosylur-
onic acid)-6-O-sulpho-D-galactose ( Di6S)) from Miles Bio-
chemicals (Frankfurt, FRG) and Sephacryl S 500 from Pharma-
cia (Freiburg, FRG). All other chemicals (E. Merck, Darm-
stadt, FRG) were of analytical grade.
Extraction of proteoglycans
The cartilages were rinsed with a sodium Chloride solution (155
mmol/1), sliced with a scalpel äs small äs possible and extracted
with 4mol/l guanidinium hydrochloride/0.05 mol/1 sodium
acetate, pH 6.0, in the presenee of 0.1 mol/1 6-amino-hexanoic
acid, 0.01 mol/1 EDTA, 5 mmol/1 benzamidine hydrochloride
and 10 mg/1 soya bean trypsin inhibitor (9). The extraction
procedures were performed twice (24H,i4°C, 10 ml/0.5 g wet
weight) and the extracts were pooled and concentrated by
ultrafiltration (4 °C) to a volume of 25 ml/sample (Immersible
CX10, Miilipore, Neu-Isenburg, FRG).
Ultracentrifugation
The proteoglycan monomers were isplated by dissociative den^
sity gradient centrifugation in caesium Chloride (starting den-
sity: 1.53 kg/l, 371000 g, 5 h, 4 °C, Beckman vertical tube rotor
VTI 65, Beckman L 8 centrifuge). Eaeh gradient was divided
into 4 fractiöns each consisting of 1.2 ml. The two high-density
bottom fractions were pooled and recentrifuged twice under
the same conditions. Density (by gravimetry), urönic acid (10)
and protein (11) were analysed in each fraction after dialysis
against doubledistilled water (3 24 h).
The bottom fractions were used for further investigatiön after
dialysis against doubledistilled water (3 24 h).
Gel chromatography
Proteoglycan samples (l ml) from the bottom fractions were
applied to a column (95 l cm) of Sephacryl S 500 and eluted
with 0.1 mol/1 sodium acetate 0.1 möl/1 sodium chloride, pH
6.8, at 9 ml/h and 4 °C Urönic acid (10) and protein (11) were
determined in each fraction (3 ml). The void volume and total
volume of the column were determined using hyaluronic acid
and glucuronolactone respectively. Hydrodynamic proteogly-
can size was estimated by calculating kav at the peak maximum
(12).
Proteoglycan monomers were mixed with hyaluronic acid (20%
based on uronic acid content) insorder to estimate their ability
to form aggregates with exogerioüs hyaluronic acid, The extent
of the interaction was determined by gel chromatography on
Sephacryl S 500 äs described above. The proteoglycans bound
to hyaluronic acid were eluted in the void volume. The hyal-
uronic acid-bourid proteoglycan portion was calculated by süb^
tracting the uronic acid content of the added hyaluronic acid
from the overall uronic acid coiitent-of the void volume.
Isolation of glycosaminoglycans
In order to detefmine the glycosaminoglyean distribution pat-
terns in the residue, in the overall extract and in the proteogly-
can monomers, glycosaminoglycans were isolated äs described
previously (13). Briefly, the samples were digested with papain
(50 mmol/1 phosphate buffer, pH 6.0, 20 mmol/1 EDTA,
5 mmol/1 cysteine, 1500 U/l papain, 16 h, 60 °C) and the nongly-
cosaininoglycan components were precipitated with concen-
trated HC1 (pH 1.5, 16 h, 4 °C). The precipitate was discarded
and the supernatant was neutralized with 3 mol/1 NaOH. After
dialysis against doubledistilled water (2 24 h), freezedrying,
ß^eh'mination in 0.3 mol/1 NaOH (4h, 4°p), neütralization
with 3 mol/1 HO, dialysis against doubledistilled water
(2 24 h) and precipitation with ethanol (5-fold volume), the
resultant glycosaminoglycans were dissolved in doubledistilled
water and analysed by the carbazol assay method (10). The
'degree of extraction was calculated from the sum of the uronic
acid in the extracts and residues. *
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Determination of glycosaminoglycan components Results
The procedure used for the analysis of glycosaminoglycan dis-
tribution patterns was based on the digestion of the polymers
by hyaluronate lyase (13), followed by chondroitinase AC and
ABC (14), s described elsewhere (15). Each enzymatic degrada-
tion step was followed by Separation of the metabolites from the
undigested glycosaminoglycans by predpitating the undigested
glycosaminoglycans with a four fold volurne of sodium acetate-
saturated ethanol (16h, 4°C). The residxie was washed twice
with l ml ethanol (96%). The supernatants from the precipita-
tion and the wash procedures were pooled, evaporated to
dryness (37 °C) and resolved in 200 μΐ doubledistilled water.
The determinations of the components were performed by high
Performance liquid chromatography of the respective metab-
olites, s described in a previous publication (16). Keratan
sulphate was analysed by determining the hexosamine content
(17) of the hydrolysed residue (2 moi/1 HCI, 16 h, 104 °Q preci-
pitated after degradation with chondroitinase ABC. Glycosam-
inoglycans corresponding to amounts of 0.5 to 1.0 μηιοί uronic
acid were used for each assay.
Uronic acid content and degree of extraction
of articular cartilage
The uronic acid concentration in the articular carti-
lage samples ranged from 10.7 to 28.8 mmol/kg wet
weight (tab. 1). The highest uronic acid concentra-
tions by far were detected in the hip and knee joints
of the 26-year-old subject. In this case, s with the
other joints, there was a high measure of consistency
between the concentrations in left and right joints.
The articular cartilages of the 45-year-old subject
had the lowest uronic acid content. There was no
systematic Variation in uronic acid content s a func-
tion of joint location.
Tab. 1. Analytical data on cartilage, residue and extract. Index number: Age of cartilage investigated.
HA = hyaluronate;
Ch = chondroitin;
CS6, CS4 = chondroitin sulphate 6 resp. 4;
DS6, DS4 = dermatan sulphate-like fractions;
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The degree of extraction was calculated from the
difference between the uronic acid content of the
articular cartilages and the extracted uronic acids.
In each case, an approximately identical degree of
extraction was recorded for left and right joints
(tab. 1). The only exceptions were the hip joints of
the 26-year-old subject. The degree of extraction did
not depend systematically on joint location, articular
cartilage uronic acid content or the subject's age.
The glycosaminoglycan distribution pattern
of proteoglycans from the residue and ex-
tract
After proteolysis, the glycosaminoglycans from the
non-extractable proteoglycans of the residue are
amenable to analysis. In order to establish whether
the extracted proteoglycans differed from those in
the residue, the glycosaminoglycan distribution pat-
terns of the extraction residues were determined and
compared with those of the extracts.
The principal components of the cartilage fractions
were chondroitin-6-sulphate and keratan sulphate
(tab. 1). Only the residue contained hyaluronic acid
(which thus proved to be non-extractable under these
conditions). The left and right sides in the 21-year-
old and 26-year-old subjects were consistent for both
fractions, given the ränge of the method. Apart from
the non-extractable hyaluronic acid, another major
difference was the higher chondroitin content in the
residue, this being especially pronounced in the shoul-
der and hip joint cartilage of the 45-year-old subject.
The differences were significant (paired t-test, p <
0.001).
In both cartilage fractions the keratan sulphate con-
tent of the glycosaminoglycans of the shoülder joints
was invariably lowest. Similarly, the chondroitin-4-
sulphate content displayed a systematic dependence
on the location of the articular cartilage, being lowest
in all knee joint cartilages. The hyaluronate content
was also lowest in each case in the extraction residues
of the knee joint cartilages from the 21-year-old and
26-year-old subjects. No such dependence was found
in the 45-year-old subject. In this instance, however,
the hyaluronate content in all joints was löwer than
in the younger subjects.
Isolation and analysis of proteoglycan
monomers
The proteoglycan monomers were isolated from the
total extract by density gradient centrifugation on a
vertical tube rotor. Because of the smaller Separation
distance, the run time required to establish the density
gradient is shorter with this rotor type than with fixed
angle rotors (18). In the rotor üsed in the preseiit
study, the gradient was established1 within 5 hours
(371000g, 65 000 min"1)· The proteoglycan mono-
mers from the densest fraction of the third run were
analysed with reference to size, h^aluronate binding
capacity, uroriic acid and protein content, and glycos-
aminoglycan distribution pattern, A fraction of about
0.8 of the extracted uronic acids was obtained after
proteoglycan isolation.
Table 2 shows that the uronic acid/protein ratio did
not depend systematically on joint location. Left- and
right-sided results for the 2i-year?old and 26-year-
old subjects were highly consistent. Analysis of hy-
drodynamic molecular size by gel chromatography
revealed that the proteoglycan monomers of the
shoülder joint cartilage were lärgest in all three sub-
jects. They had both the highest portion of molecules
eluted with the void volume (fig. 1) and the lowest
individual kav values. The proteoglycan monomers
from the hip and knee joint cartilages differed only
slightly. No correlation was established between the
uronic acid/protein ratio and kav.
Tab. 2. Characteristic data on proteoglycan monomers: uronic
acid/protein weight ratio, kav calculated at peak max^
imum of gel chromatography, and the fraction of hyal-
uronäterbinding proteoglycan monomers. The interac-
tion with hyaluronate was quantified by determinhig
the fraction of proteoglycan uronic acid coeluted with
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Fig. 1. Gel chromatography of proteoglycan monomers isolated from cartilage from the right-sided joints of the subjects.
(Sephacryl S 500; 0.1 mol/1 sodium acetate / 0.1 mol/1 sodium Chloride, pH 6.8; 9 ml/h.)
Proteoglycans form link-protein-stabilised complexes
with hyaluronate iii vivo (19 — 21). Complex forma-
tion in the absence of link protein in vitro occurs s
a reversible equilibrium reaction (22, 23). Complex
formation is temperature-dependent (23, 24). The ex-
periments to determine the portion of complex-bind-
ing proteoglycan monomers were therefore con-
ducted at constant teinperature (4 °C) and under hy-
aluronate excess in order to force the equilibrium s
far s possible towards the complex. Excess uronic
acid here does not interfere with hyaluronate-proteo-
glycan complex formation (23). The analyses were
performed by gel chromatography. The hyaluronate
used was eluted with the void volume (fig. 2). The
hyaluronate binding eapacity was calculated s the
percentage portion of the proteoglycan monomers
coeluted with hyaluronate in the void volume (calcu-
lation based on uronic acid). The proteoglycan mono-
mers of the shoulder and hip joints of the 21-year-
old and 26-year-old subjects were characterised by
100% hyaluronate binding eapacity.
Complex formation was observed in only 90% of the
proteoglycan monomers from the knee joint cartila-
ges of these two subjects. In the case of the 45-year-
old subject, the hyaluronate binding eapacity of the
proteoglycan monomers was limited to about 40%
(tab. 2, fig. 2); however, no systematic pattern depen-
dent on joint location was detected here either.
To permit determination of the glycosaminoglycan
distribution patterns, the proteoglycan monomers
from left and right-sided joints from the 21-year-old
and 26-year-old subjects were pooled so s to provide
a sufficient quantity for a complete analysis. As in the
corresponding analyses of the glycosaminoglycans in
the residues and extracts, chrondroitin-6-sulphate
J. Clin. Chem. Clin. Biochem. / Vol. 23,1985 / No. 12
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Fig. 2. Determination of hyaluronate-binding proteoglycans. A = proteoglycan mpnomers isolated from the knee joint cartilage
of the 21-year-old subject. B = proteoglycan monomers isolated from the knee joint cartilage of the 45-year-old subject.
Chromatography was performed with and without hyaluronate (HA) added. B%%! = hyaluronate alone. Conditions of
chromatography: Sephacryl S 500; 0.1 m l/1 sodium acetate / 0.1 mol/1 sodium Chloride, pH 6.8; 9 ml/h.
and keratan sulphate were found to be the principal
constituents (tab. 3). As anticipated, hyaluronate was
not detected in any sample. One notable systematic
Variation dependent on joint location was the fact
that the keratan sulphate content of shoulder joint
cartilage was lowest in each individual subject. As
with the distribution patterns of the two cartilage
fractions in table l, the proteoglycan monomers of
the knee joints had the lowest chondroitin-4-sulphate
content in each case here (tab. 3). All other compo-
nents failed to display any systematic Variation s a
function of joint location. Overall, in the case of
the 45-year-old subject, the content of chondroitin-6-
sulphate was lowest and the content of keratan sul-
phate was highest of all the subjects examined.
Discussion
Method
Human articular cartilage contains a heterogeneous
proteoglycan population. Thus, systematic intraarti-
cular structural changes have been described s a
function of distance from the cartilage surface (25,
26). Given the uniform macroscopic and histological
intactness of the cartilage samples in the present
study, this heterogeneity was ignored since its effect
on the analytical results was presumably identical
for each sample. Extraction yields are affected to a
considerable degree by the technique used for tissue
comminution (26). The yields reported in the litera-
ture for adult human articular cartilage (50—60% of
uronic acid) (7, 23) were achieved with the technique
employed here. Since the cartil ge discs were certainly
250 μιη or more thick, it was not possible (see also
Bayliss (26)) to extract hyaluronate because section
thicknesses of the order of 100 μιη are required in
order to achieve this.
The uronic acid/keratan sulphate f atios in the residue
and extract did not differ significantly (tab. 4, p >
0.2, paired t-test). There was therefore no selection
of the proteoglycan monomers by extraction with
respect to their glycosaminoglycan composition, such
s reported by Bayliss et al. (26) for the articular
cartilages of subjects approximately 75 years old. In
our own experiments, significantly lower uronic acid/
keratan sulphate ratios in the extracts have also only
been detected in the articular cartilage of oider sub-
jects (62-74 years old) (27, 28). Consequently, aii
effect may be postulated which only oecurs in subjects
of more advanced age. In agreement with this theory,
the structural differences in proteoglycans dependent
on joint location in the subjects examined here were
encountered both in the non-extractable and iri the
extracted fractions.
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Tab. 3. Glycosaminoglycan distribution patterns of proteogly-
can monomers. Data in mol% of total glycosaminogly-
cans. Proteoglycan monomers from the left and right
joints from the 21-year-old and 26-year-öld subjects
were pooled.
Ch = chondroitin;
CS6, CS4 = chondroitin sulphate 6 or 4;
DS6, DS4 = dermatan sulphate-like fractions;









































































Tab. 4. Uronic acid/keratan sulphate and chondroitin-6-sul-
phate/chondroitin-4-sulphate molar ratios calculated
from tables l, 2 and 3- Samples from left and right
joints were pooled for the analysis of proteoglycan




































































































































In agreement with earlier investigations (l 3), determi-
nation of the glycosaminoglycan distribution patterns
repeatedly disclosed a fraction which was not digest-
able by chondroitinase AC but was digestable by
chondroitinase ABC. More extensive investigation
revealed that these were tetra- and hexasaccharide
fragrnents which were sulphated predominantly at
the C4 atom of the galactosamine and could not be
digested by chondroitinase AC even when isolated
(16). This fraction should represent cartilage derma-
tan sulphate (14). However, one has to consider that
these oligosaccharides contaih one -ß unsaturated
carbonic acid at their non-reducing end, which has
been formed from glucuronic acid. This part of the
oligosaccharides formally should be derived from
chondroitin sulphate. In contrast, it has been re-
ported that dermatan sulphate is a hybrid molecule
always containing glucuronic acid moieties äs integral
parts of the carbohydrate chains (29). Hitherto no
additional data on the molecular structure of carti-
lage dermatan sulphate polysaccharide chain have
been repqrted. Therefore, in view of the specifity of
the enzymes, this fraction was assigned to "dermatan
sulphate like".
The effect of joint location on the structure
of cartilage proteoglycans
The results indicate that, in the subjects examined,
intra-individual structural differences exist, which de-
pend on joint location. Thus, the proteoglycan mono-
mers from the high weight-bearing knee and hip
joints were invariably smaller than those from the
low weight-bearing shoulder joints. This finding may
presumably be attributed to a smaller chondroitin
sulphate^rich region since the uronic acid/keratan
sulphate ratios were arlso always lower in the high
weight-bearing joints (tab. 4). Furthermore, the two
'high weight-bearing joints (knee and hip) differed in
all three cartilage fractions in terms of their chondro-
itin-6-sulphate/chondroitin-4-sulphate ratio: the
highest ratio was always found in the knee joint
(tab. 4). These results are not consistent with those
of Roughley (7) who found no significant differences
in the molecular size and structure of the proteogly-
can monomers of shoulder joint cartilage compared
with those of the knee. However, his subjects were
very young (all were 0—15 years old, except one who
was 34 years old). It may be that these differences
only become apparent'in adult subjects. This is es-
pecially probable if functional causes could be found
for the variations.
A reduction in the size of the chondroitin sulphate-
rich region with increasing age has been described
for human cartilage proteoglycans (30, 32). This find-
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ing has been attributed to reduced UDP-xylose: core
protein xylosyl transferase activity with increasing
age (33). The smaller chondroitin sulphate-rich region
in the knee and hip joints could thus be ascribed to
more rapid ageing due to higher weight-bearing. Since
weight-bearing continues äs the subject grows older,
the differences in the size of the condroitin sulphate-
rich regions of the proteoglycans of shoulder joint
cartilage on the one hand and of knee and hip joint
cartilage on the other should become increasingly
pronounced.
The chondroitin-6-sulphate/chondroitin-4-sulphate
ratio in human articular cartilage increases with age
(31, 34). However, the chondroitin-6-sulphate/chon-
droitin-4-sulphate ratio of the high weight-bearing
articular cartilages is not consistent with the picture
of premature ageing. More rapid ageing of the hip
and knee joint cartilage should result in a higher ratio
of chondroitin sulphate isomers. In fact, this was only
found for the.knee joints of the 21-year-old and 26-
year-old subjects; in contrast, the data for the shoul-
der and hip joints were consistent (tab. 4). If the
process of ageing is induced by the biomechanical
stress, these differences between the high and the low
weight-bearing joints should increase with increasing
age. However, in the 45-year-old subject, these differ-
ences were only äs marked äs in the younger subjects
in the residue and the extract. The differences in
the chondroitin-4-sulphate content of the articular
cartilage äs a function of joint location cannot there-
fore be interpreted äs indicating more rapid ageing
of the weight-bearing knee and hip joints.
Arthrosis-induced changes in the structure of carti-
lage proteoglycans are characterised by a reduction
in molecular size äs a result of damage to the hyal-
uronate binding region (3). Thist ,is possibly caused
by proteolytic destruction (35, 36) and altered syn-
thesis in the chondrocytes (37, 38). The results of the
present study do not offer any clear evidence of
corresponding changes in the high weight-bearing
articular cartilages. Thus, the hydrodynamic molecu-
lar size of the proteoglycans was not paralleled by
either a defmite restriction of hyaluronate binding
capacity or any systematic change in the uronic acid/
protein ratio. Where pronounced biomechanical
stress on the articular cartilages also produces
arthrosis-like changes in proteoglycan structure, these
only appear to develop in relatively elderly subjects.
Our results have shown that the proteoglycans of the
knee and hip joint cartilages were smaller than those
of the shoulder joint cartilages because of the reduced
chondroitin sulphate-rich region. The structural vari-
ations are biomechanically induced. However, it is
not yet clear, whether they are the result of functional
strain or/and of stress by weight-bearing. The differ-
ences do not fit in with the pattern of either age-
induced or arthrosis^induced changes. More extensive
investigations in healthy articular cartilage are re-
quired tö clarify this state of affairs, and appropriate
studies are in progress in öur laboratory.
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